DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state
about
How grim is hepatocellular carcinoma?Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteinsCurrent progress in the development of therapeutic vaccines for chronic hepatitis B virus infectionA randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients.Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccinationCimetidine synergizes with Praziquantel to enhance the immune response of HBV DNA vaccine via activating cytotoxic CD8(+) T cell.Antigen-antibody complex as therapeutic vaccine for viral hepatitis B.New vaccine developmentAltering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune responseCpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice.Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection.Phage display creates innovative applications to combat hepatitis B virusBoosting immune response to hepatitis B DNA vaccine by coadministration of Prothymosin alpha-expressing plasmid.Evolving therapies for the treatment of chronic hepatitis B virus infection.DNA-based immunotherapy: potential for treatment of chronic viral hepatitis?Lentivector expressing HBsAg and immunoglobulin Fc fusion antigen induces potent immune responses and results in seroconversion in HBsAg transgenic mice.Immunizations with hepatitis B viral antigens and a TLR7/8 agonist adjuvant induce antigen-specific immune responses in HBV-transgenic miceAttempted therapeutic immunization in a chimpanzee chronic HBV carrier with a high viral loadUse of pre-S protein-containing hepatitis B virus surface antigens and a powerful adjuvant to develop an immune therapy for chronic hepatitis B virus infection.Gene therapy of liver diseases.Contribution of C3d-P28 repeats to enhancement of immune responses against HBV-preS2/S induced by gene immunizationDNA immunization with fusion genes encoding different regions of hepatitis C virus E2 fused to the gene for hepatitis B surface antigen elicits immune responses to both HCV and HBVEscaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection.Humoral and cellular immunogenecity of DNA vaccine based on hepatitis B core gene in rhesus monkeysTherapeutic vaccination in chronic hepatitis B virus carriers.Immunomodulation as an option for the treatment of chronic hepatitis B virus infection: preclinical studies in the woodchuck model.Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.Codon usage roles in human papillomavirus.Gene therapeutic approaches to inhibit hepatitis B virus replication.Prospects and progress of DNA vaccines for treating hepatitis B.Present and future DNA vaccines for chronic hepatitis B treatment.Identification of antigenic regions of duck hepatitis B virus core protein with antibodies elicited by DNA immunization and chronic infection.Horizontal gene transfer events reshape the global landscape of arm race between viruses and homo sapiens.Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants.Pathobiology of acute and chronic hepatitis B virus infection: an introduction.Synergistic and additive effects of cimetidine and levamisole on cellular immune responses to hepatitis B virus DNA vaccine in mice.Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.Immune therapy of hepatitis B virus chronic infection.Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study.In vivo infectivity of liver extracts after resolution of hepadnaviral infection following therapy associating DNA vaccine and cytokine genes.
P2860
Q27001669-69405F80-04CD-4896-8D9C-7692C8912EB3Q27470000-3B9C34BF-D649-4563-93B9-9CBCD68ED2A9Q28076279-DB5CB365-B8C6-4465-BEE7-BF2F093E1FFDQ33348606-250DE7F4-94BC-40AF-8328-2297CA93CED5Q33525552-AEB1D19A-1CEE-4FED-B6A8-9940C368A11FQ33578026-6C8ED450-09D1-4BC8-99AE-26403A52C08BQ33805869-CDB8C10D-84C2-4561-B0FE-085152AA0210Q33810625-D262C9B0-B959-4525-82BD-5116E1B27AC3Q33825265-84D26C70-D88F-4FB8-918F-325032C24771Q33843264-50247B56-95C4-4B42-8DEA-051D96665E31Q33988059-8231057C-DC71-4FF5-979D-83BBE16F3B0EQ34137308-0566605B-6357-41D3-B5F2-595473427029Q34231216-64967075-C75A-459A-AB55-843431A3CA39Q34519117-383EF4B2-FB6C-42A3-98C4-A0B685AD1AC5Q34812028-2B9E10BD-2CAD-4740-B39E-61A794636B5FQ34958663-2CDDA7DE-024B-49F4-A4A2-B2C8894A2EF4Q35424070-B848EF28-F8A6-415E-BD27-7FF4DC9FEFC6Q35574310-00D1389C-37DC-43AC-BF4C-1115F7DEBC43Q35739131-4C0CD3FA-305E-4D99-9CA1-BFD354B6C6E9Q35842662-E7EE3212-4A47-4E46-88B1-CC3EFC29FF67Q36066222-1ABAD42D-99AF-488F-8417-B32F875BDA72Q36308565-B1F418A8-406A-4704-AA21-07082A54D626Q36370173-59367029-37EE-4E03-9EBE-8176148B1A70Q36397263-5FA5B732-EF26-454F-97CB-19181B257A68Q36689035-EDE1C624-604E-453D-ABB4-AEF10ADD7C8FQ36821357-AD7FF51E-3432-41EA-8C4A-A0F53DE0ADBEQ36990647-B209962A-AE14-4692-AAFF-A64F4F348DC9Q37949297-7AA158BC-B811-442A-96F2-47D833AB3F29Q38366585-89A4D829-4689-4B18-AAA0-96F773D9816DQ38664504-0ED0CB83-E45B-4651-8ADE-A38AB2FC818AQ38790065-642E65DA-8C9B-44F7-8E47-D2C19E0BD73EQ40677965-C9DE4D48-F40E-4363-87BA-39E2854A6ED5Q40715182-A71494BF-3421-4CA3-AC2A-A9B59B0D8AC0Q41558472-59BFCF78-0BD1-49F0-8ECF-B38024A058A4Q41681569-22582E9D-E2B7-455A-A137-8D1338A4876FQ45353160-089F0F58-D37B-48F6-9045-2B76CCE4D701Q45737159-83F6BEBC-CCD0-4FEF-95D7-5C71EA27B930Q45744179-29559D66-ED35-4883-ADFD-74E33A233BDFQ45856638-F0F0556E-1087-40FF-9814-DF3AC8E2AC90Q46773926-DB606060-2FCD-49EA-9FDA-35EC38541565
P2860
DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state
description
1996 nî lūn-bûn
@nan
1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
DNA-mediated immunization in a ...... antigen chronic carrier state
@ast
DNA-mediated immunization in a ...... antigen chronic carrier state
@en
DNA-mediated immunization in a ...... antigen chronic carrier state
@nl
type
label
DNA-mediated immunization in a ...... antigen chronic carrier state
@ast
DNA-mediated immunization in a ...... antigen chronic carrier state
@en
DNA-mediated immunization in a ...... antigen chronic carrier state
@nl
prefLabel
DNA-mediated immunization in a ...... antigen chronic carrier state
@ast
DNA-mediated immunization in a ...... antigen chronic carrier state
@en
DNA-mediated immunization in a ...... antigen chronic carrier state
@nl
P2093
P2860
P3181
P356
P1476
DNA-mediated immunization in a ...... antigen chronic carrier state
@en
P2093
M Hadchouel
M L Michel
R G Whalen
P2860
P304
P3181
P356
10.1073/PNAS.93.22.12496
P407
P577
1996-10-29T00:00:00Z